Safety and Effectiveness of the Opira AIOL in Comparison to Commercial IOLs in Patients Undergoing Cataract Surgery
Evaluation of the Visual Performance and Safety of the Investigational Opira AIOL, A Commercial Multifocal IOL, and a Commercial Monofocal IOL
1 other identifier
interventional
200
2 countries
2
Brief Summary
This is a clinical trial comparing an investigative accommodative IOL and two commercial IOLs in patients with cataracts undergoing primary cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2020
CompletedFirst Submitted
Initial submission to the registry
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
February 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFebruary 14, 2023
June 1, 2022
3.2 years
February 12, 2021
February 13, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Acuity
6 Months
Adverse event rates
12 Months
Study Arms (3)
Opira AIOL
EXPERIMENTALMonofocal AIOL
ACTIVE COMPARATORMultifocal AIOL
ACTIVE COMPARATORInterventions
The surgical procedure in which the natural crystalline lens is removed and replaced with a lens implant.
Eligibility Criteria
You may qualify if:
- Male and female subjects aged 50-75 with bilateral cataracts, good potential vision, and clear intraocular media other than lens opacity
You may not qualify if:
- Comorbidities affecting visual acuity, IOP \> 22mmHg, congential cataract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FSV6, Ltd.lead
Study Sites (2)
Clinica 2020
San José, Costa Rica
Codet Vision Institute
Tijuana, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2021
First Posted
February 16, 2021
Study Start
October 8, 2020
Primary Completion
January 1, 2024
Study Completion
June 1, 2024
Last Updated
February 14, 2023
Record last verified: 2022-06